Israel Active

As cells age, they stop dividing. Our immune system removes them, but they build up as we age. Scientists say that all these “senescence cells” must be removed to prevent aging, but scientists at Israel’s Weizmann Institute have discovered that those formed after heart injury are needed, to protect the heart.

Israel’s AIVF (see previously) reports that its EMA embryo analysis platform is 38% more accurate than the eye of a trained embryologist when assessing which IVF embryo is most likely to result in a successful pregnancy. AIVF is active in Europe, Australia, Brazil, and South Korea.

Israel’s Salignostics (see previously) is working with Israel’s Sheba Medical Center to develop a saliva test for the early detection of oral cavity cancer. It may save some of the 400,000 diagnosed with oropharyngeal cancer, of whom only 50% will survive five years after diagnosis.

It was Eden Golan day at United Hatzalah’s gala fundraiser event in Manhattan. After delivering the first US performance of her song “Hurricane” and other songs, she received United Hatzalah’s “Hero Award”. The event raised $20 million for ambulances, e-bikes, and other equipment.

The World Economic Forum selected Israel’s Brain.Q (see previously) for the 2024 cohort of WEF Technology Pioneers. Brain.Q will contribute cutting-edge insights and expertise to the Forum’s global initiatives over the next two years, helping to scale their impact.

The current 3-month SPARC training course for nurses at Israel’s Sheba Medical Center includes participants from Australia, Brazil, Germany, Japan, Nigeria, South Africa and the US. It selects innovative nurses who have ideas for life-saving solutions that they can develop into practice.

Haifa University governors laid the cornerstone of the Herta and Paul Amir School of Medicine. The 1,200-bed hospital is due to open in 2025, featuring state-of-the-art medical services; patient-centered care; hi-tech ICUs; and cardiovascular, thoracic, and surgical oncology departments.

Israel’s Air Doctor (see previously) now has 20,000 doctors registered to its service globally, partnering with insurance companies in 80 countries. It has also added video telemedicine consultations on their platform and reduced insurance claim costs by 54%.

The French-based Human Frontier Science Program (HFSP) funds basic research in life sciences. It has awarded a $1.2 million grant to Ben Gurion University Prof Michael Meijler to investigate how certain gut bacteria affect human behavior, such as anxiety and stress.

A detailed article about Israel’s Remepy (see previously). It has completed three clinical trials involving 200 patients, using its digital molecules to treat cancer, MCI (Mild Cognitive Impairment) and Parkinson’s. It aims to bring its first product to market within three years.